Register Now Register Now

C8: The Impact of Physical and Chemical Parameters on the Exposure of Hazardous Drugs in the Workplace

Amy Snow, MHS, CIH, CSP Moderator
SafeBridge, Consultants INC.
Wake Forest, NC 
USA
 
Janet Gould, PhD, DABT, CIH Presenter
SafeBridge Consultants, Inc.
East Brunswick, NJ 
 
Matthew Meiners, CIH Co-Presenter
SafeBridge Consultants, Inc.
Woodstock, IL 
USA
 
Mon, 5/19: 2:00 PM - 3:00 PM CDT
00315 
Education Session 
Kansas City Convention Center 
Room: 3501 H 
CM Credit Hours:

Description

Physical and chemical properties of chemicals impact the potential for inhalation and dermal exposure. Key properties will be evaluated as they relate to hazardous drug (HD) exposure. The potential for exposures to vapors from HDs has been a common misconception in the healthcare industry. This presentation will provide evidence that the vapor pressure of the NIOSH listed HDs is generally minimal and will be applied to an exaggerated exposure case study example with cyclophosphamide demonstrating extremely low exposure potential from HD vapors. This indicates that dust and aerosol evaluation is the appropriate sampling approach for potential inhalation exposure. Dermal route of exposure is of concern in the healthcare setting. The second evaluation presented here will investigate how the potential for dermal absorption of HDs contributes to a possible internal dose. Physical and chemical parameters (i.e., molecular weight, octanol-water partition coefficient, and water solubility) were used with in silico models to predict dermal absorption potential. These results can then feed into the toxicological assessment and determination of an acceptable surface limit (ASL).

Learning Outcomes

After listening to this presentation, the attendee should be able to:

Demonstrate that vapor pressure is relatively low indicating very low HD exposure by inhalation and aerosol evaluation techniques are most appropriate.

Strengthen knowledge about in silico models to estimate dermal absorption for HDs to support acceptable surface limit determination. 

Content Level

Intermediate

Interactive Session Experience

Q&A

Organizational Category

Corporation/Company

Primary Industry

Healthcare/Pharma
Laboratories
Manufacturing

Topics

Available as part of AIHA Connect OnDemand
Hazard Recognition/Exposure Assessment
Health Care
Toxicology